This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional. 

(PEA) is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acyolethanolamines family of lipid mediators . 

 

Features

- PEA is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-axylethanolamines famiyl of lipid mediators 

- PEA Liquid is micronised to a 20um-25um particle size using laser diffraction 

- Presented in a coconut-derived (MCT) lipid suspension for ease of compounding 

- 2mL contains 300mg PEA for easy dose calculation

- Synthesised from palmitic acid from sustainably sourced palm oil, RSPO certified palm oil 

- PEA Liquid contains 99% pure PEA, which has been confirmed by purity testing 

- Low allergen, clean formula. Pleasant natural orange flavour. 

Ingredients

Each 2 mL contains:

Palmidrol (Palmitoylethanolamide)                                                             300mg

In a base of medium chain triglycerides (fractionated coconut oil), ethanol and cold pressed orange oil.

Dosage 

For extemporaneous compounding by a qualified health professional.

Information for compounding: 2mL provides 300mg of palmitoylethanolamide 

Cautions

- Compounding preparations should be supplied to an individual only after consultation with a health professional 

- It is required that a label is attached to the medicine providing instructions for use for the individuals 

- Contains ethanol 6% v/v as a preservative

- KEEP OUT OF REACH OF CHILDREN

- Do not use if seal on cap is broken.

- Shake well before use